The quality of scientific research depends on the quality of data generated by research facilities, much of which remains unavailable to the greater scientific community, bioinformatician Isabel Duarte writes. "Genetic research is still very expensive, and if one cannot reuse the data for further analysis, millions of dollars of public money will have gone to waste, harming most of all each and every individual waiting for a cure, while hindering the progress of genetic research," she writes. Government entities, patient advocacy groups, the scientific community and the general public should work to open access to data and implement policies that help ensure a return on investments in genomic science, she writes.

Related Summaries